Skip to Main Content

Paper Details

Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response.
Clin Cancer Res
31
2022
Author NameAffiliation
Elizabeth M JaffeeThe Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Elizabeth M JaffeeCancer Convergence Institute, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
  • 1 - 2

Datasets

Release 1.2